Company Analysis

TuHURA Biosciences, Inc. (HURA)

Nasdaq: HURA · Pharmaceutical Preparations · Tampa, FL · filing with the SEC since 2010
Grade4.1
◀ Past 4.2● Present 2.9▶ Future 5.2
5 est.

Who runs TuHURA Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Bianco James A.
Chief Executive Officer. First filing Oct 2024, latest May 29, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
21 people on the record since 2013
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Bianco James A.Chief Executive OfficerOct 2024May 29, 2026none
Hoffman Robert E.President, CEO and Interim CFOApr 2018Feb 17, 2026none
Dearborn DanChief Financial OfficerOct 2024Jan 8, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
List AlandirectorOct 2024Feb 17, 2026none
Manuso James S JdirectorOct 2024Feb 17, 2026none
Ng George KdirectorOct 2024Feb 17, 2026none
Tendler CraigdirectorMar 2025Feb 17, 2026none
Earlier names on the record15, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton HURA · research, not advice